Cytokines are small, secreted molecules that regulate an array of cellular processes, including hematopoietic differentiation and responses to infection or injury (1) . As highly potent molecules, both cytokine secretion and responses to cytokines are tightly regulated processes. In the absence of appropriate regulation, autoimmune and autoinflammatory diseases may occur. Clearly, maintaining homeostasis of the immune system requires delicate regulation of cytokine production and action.
SOCS-1 1 is the prototypic member of a family of cytokine inhibitors (2) . Originally isolated as a negative regulator of interleukin-6 (IL-6) action (3) (4) (5) , subsequent studies have shown that SOCS-1 inhibits a wide range of cytokines in vitro (6 -8) . Analyses of mice lacking SOCS-1 have, however, shown SOCS-1 to have a more specific physiological role. SOCS-1 Ϫ/Ϫ mice die neonatally of a severe inflammatory disease that is characterized by fatty degeneration of the liver and abnormal T cell activation (4, 9 -11) . Disease in SOCS-1 Ϫ/Ϫ mice appears to result from the combination of increased IFN␥ levels and a heightened sensitivity to IFN␥, indicating that SOCS-1 is a key regulator of this inflammatory cytokine (11) (12) (13) .
In contrast to SOCS-1 Ϫ/Ϫ mice, SOCS-1 Ϫ/Ϫ IFN␥ Ϫ/Ϫ mice survive until adulthood and appear healthy (12) . These mice are not, however, completely normal and inflammatory infiltrates eventually develop, resulting in a reduced lifespan (14, 15) . These findings suggest that SOCS-1 may be an essential physiological regulator of other cytokines in addition to IFN␥ and that dysregulated responses to these cytokines may contribute to disease development in SOCS-1 Ϫ/Ϫ mice. In particular, it is unclear why IFN␥ levels are elevated in SOCS-1 Ϫ/Ϫ mice, and it is possible this abnormality results from uncontrolled signaling in response to cytokines other than IFN␥.
IL-12 is a cytokine that may contribute to SOCS-1 Ϫ/Ϫ disease development based on its ability to induce IFN␥ production by activated natural killer (NK) and T cells (16 -19) and its important role in T cell regulation (20 -24) and inflammatory diseases such as colitis (25, 26) . IL-12 is primarily produced by macrophages and dendritic cells in response to various intracellular pathogens or pathogen products (27) (28) (29) . Once produced, IL-12 acts upon activated T cells and NK cells to induce their proliferation, cytotoxicity, and IFN␥ production (16 -19, 30 -33) . IL-12 exerts its biological effects by binding to the IL-12 receptor (IL-12R), which is composed of two subunits, ␤1 and ␤2 (34 -36) . Expression of the IL-12R ␤2 subunit is rapidly up-regulated following activation of NK and T cells, enabling these cells to respond to IL-12 (37, 38) . IL-12 interacts with functional IL-12R on the cell surface and activates cytoplasmic signal transduction pathways, including the Janus kinases/ signal transducers and activators of transcription (JAK/STAT) signaling pathway (39, 40) . In vivo studies have shown that STAT4 is a critical mediator of IL-12-induced responses (41, 42) .
Inflammatory diseases that appear to result from either the overproduction of IL-12 or heightened sensitivity to this cytokine demonstrate that both IL-12 production and signaling require strict regulation (25, 26) . Although cytokines such as IL-10 appear to regulate IL-12 production (43), the mechanisms that control IL-12 signaling remain to be elucidated. One possibility is that IL-12 signaling may be regulated by inhibitory molecules such as the SOCS proteins. This study examines IL-12-induced responses in SOCS-1-deficient cells and provides evidence that SOCS-1 regulates responses to IL-12 in vivo.
EXPERIMENTAL PROCEDURES
Mice-All mice were bred and housed in clean but not specific pathogen-free conditions at the Walter and Eliza Hall Institute of Medical Research. SOCS-1 Ϫ/Ϫ mice on a 129/Sv ϫ C57BL/6 background were generated as described previously (9) and then were backcrossed at least 10 generations to C57BL/6. IFN␥ Ϫ/Ϫ mice on an inbred C57BL/6 background (C57BL/6-tmlTs ) were obtained from Jackson Laboratories (Bar Harbor, ME). SOCS-1 ϩ/ϩ IFN␥ Ϫ/Ϫ and SOCS-1 Ϫ/Ϫ IFN␥ Ϫ/Ϫ mice were generated either on a mixed 129/Sv ϫ C57BL/6 background as described previously (12) , or on a C57BL/6 background, by mating SOCS-1 ϩ/Ϫ (backcrossed 10 generations to C57BL/6) with IFN␥ Ϫ/Ϫ mice. Mice were genotyped for the SOCS-1 gene by Southern blot analysis of genomic DNA obtained from tail tips, as described (9) . STAT4 Ϫ/Ϫ mice on a mixed 129/Sv and BALB/c genetic background were generated as described previously (41) and were mated with SOCS-1 ϩ/Ϫ mice. SOCS-1 ϩ/Ϫ STAT4 ϩ/Ϫ mice were then interbred to generate mice of the various genotypes required for the study.
Mice were genotyped for STAT4 by PCR analysis of genomic DNA obtained from tail tips, using a protocol kindly provided by Dr. Mark Kaplan (Indiana University School of Medicine, Indianapolis). Briefly, wild type and knockout alleles were amplified in a single PCR reaction using a mixture of three oligonucleotide primers; a 5Ј STAT4 oligo (5Ј-gac agc aac tgg aga aac tac agg agc-3Ј), a 3Ј STAT4 oligo (5Ј-ctg agt cag ctg ctg gga gaa gag gtg-3Ј) and to amplify the knockout allele, a neo primer (gct acc cgt gat att gct gaa gag). PCR was performed using 40 cycles of 96°C for 30 s, 55°C for 30 s, and 72°C for 30 s. Wild type and knockout STAT4 alleles were amplified to produce 320 and 250 bp PCR products, respectively.
Full histological analyses of mice were performed as described previously (15) . Briefly, tissues were fixed in 10% buffered formalin and sectioned and stained with hematoxylin and eosin.
Cell Culture and Cytokines-Unless otherwise stated, for all assays cells were cultured in mouse tonicity RPMI 1640 containing 10% (v/v) fetal calf serum and 5 ϫ 10 Ϫ5 M 2-mercaptoethanol, at 37°C in a humidified cell incubator containing 10% (v/v) CO 2 . Recombinant murine (rm) IL-12 was purchased from R&D Systems (Minneapolis, MN).
Flow Cytometry-Single cell suspensions prepared from mesenteric lymph node were depleted of red blood cells and then resuspended in 50 l of saturating amounts of 2.4G2 anti-Fc␥ receptor antibody containing 10% (v/v) normal rat serum, and stained with cocktails of fluorochrome-conjugated antibodies specific for CD4, CD8, or CD44, as described previously (44) . Cells were analyzed using a FACScan (Becton Dickinson, Franklin Lakes, NJ) with CellQuest Software. Dead cells and erythrocytes were excluded by propidium iodide staining (1 g/ml) and gating of forward angle and side scatter.
T Cell Proliferation Assay-Dispersed cell suspensions were prepared from superficial cervical, axillary, brachial, renal, mesenteric, and inguinal lymph nodes from either sick SOCS-1 Ϫ/Ϫ mice (7-15 days old) and their healthy wild type littermates; or SOCS-1 Ϫ/Ϫ IFN␥ Ϫ/Ϫ (4 -7 weeks old) and age-matched SOCS-1 ϩ/ϩ IFN␥ Ϫ/Ϫ mice. Lymph node cells from mice of the same genotype were pooled (4 -6 mice/pool) and enriched for T cells using Mouse T Cell Enrichment Columns (R&D Systems) according to the manufacturer's protocol. FACS analysis showed T cell populations were typically greater than 98% pure.
T cells were cultured in 96-well U-bottomed plates at a density of 5 ϫ 10 5 cells/well. Appropriate wells were coated with 10 g/ml anti-CD3 antibody (clone KT3-1-1) for at least 1 h at 37°C, and then antibody was aspirated prior to adding cells. Cultures were stimulated with 0 -1000 units/ml rmIL-12 in the presence of 20 g/ml rat anti-mouse IL-2 antibody (clone JES6 -1A12, R&D Systems), and cultured for 1-5 days. [H 3 ]thymidine (1Ci/well; Amersham Biosciences) was added 17 h before harvest of the cultures. Radioactivity was measured using a scintillation counter (Packard, Meridin, CT), and the results were expressed as mean cpm Ϯ S.D. of triplicate cultures.
IL-12 Receptor Expression-Lymph node T cells were purified as described above and then fixed and permeabilized using a Cytoperm/ Cytofix kit (PharMingen, San Diego, CA) according to the manufacturer's protocol. In parallel, T cells were stimulated as described for the proliferation assays, with anti-CD3 antibody and either 0.5 or 50 units/ml rmIL-12. Anti-IL-2 antibody (20 g/ml) was included in all assays. For the next 4 days, replicate samples of the cells were fixed and permeabilized. Fixed cells were incubated with 1 g/ml of either polyclonal anti-IL-12R antibody (Santa Cruz Biotechnology, Santa Cruz, CA) or, as a control, polyclonal anti-IL-11R antibody (Santa Cruz Biotechnology). Receptor binding was then detected using 1:200-diluted FITC-conjugated sheep anti-rabbit antibody (Amersham Biosciences) and analyzed by FACS.
NK Cell Cytotoxicity Assay-Spleens were harvested from SOCS-1 Ϫ/Ϫ IFN␥ Ϫ/Ϫ mice (5-6 weeks old) and age-matched SOCS-1 ϩ/ϩ IFN␥ Ϫ/Ϫ mice (n ϭ 3 mice/genotype), and cell suspensions were red blood cell-depleted. Splenocytes of the same genotype were pooled and cultured overnight at 37°C in 6-well plates at a density of 1 ϫ 10 7 cells/ml, in the presence of 0 -1000 units/ml rmIL-12. The following day, splenocytes were washed twice and added to 96-well plates in graded dilutions to obtain the desired Effector:Target (E:T) ratios of 90:1, 20:1, 10:1, 5:1, and 1:1.
The NK-susceptible cell line, YAC-1, was kindly provided by Dr. Mark Smyth (Peter MacCallum Cancer Institute, Melbourne). YAC-1 cells were labeled with 100 Ci of 51 Cr (PerkinElmer Life Sciences) for 1 h at 37°C, washed three times, and plated at 10 4 cells/well into plates containing appropriately diluted effector cells. After 4 h at 37°C, plates were spun, and supernatants were counted in a scintillation counter (Packard). YAC-1 cells were incubated in media alone or in the presence of 10% (v/v) SDS to determine spontaneous and total release, respectively. Specific lysis was calculated by % lysis ϭ (E Ϫ S)/(T Ϫ S) ϫ 100, where E is the release from experimental samples, S is the spontaneous release, and T is the total release.
Statistical Analysis-Microsoft Excel was used for all statistical analyses. Data from in vitro assays were analyzed using a one-tailed Student's t test for independent events with the assumption of equal variance. For the analysis of SOCS-1/STAT4 mice, age-matched mice pairs were compared using a one-tailed Student's paired t test.
RESULTS
The deleterious effects of continued IL-12 signaling are evident in inflammatory disorders such as Crohn's disease (45) . Therefore uncontrolled responses to IL-12 may contribute to the severe inflammatory disease in SOCS-1 Ϫ/Ϫ mice. To investigate this, in vitro assays were developed to measure IL-12 responses by the two major IL-12-responsive cell types, NK and T cells.
SOCS-1-deficient T Cells Are Hyper-responsive to IL-12-Firstly, we assessed IL-12-induced proliferation of SOCS-1
Ϫ/Ϫ T cells. In order to measure proliferation in response to IL-12 alone, a neutralizing antibody to IL-2 was included in all assays. Initially, we assayed purified lymph node T cells from SOCS-1 Ϫ/Ϫ and control mice in the absence of activation with anti-CD3. Under these conditions, T cells are expected to be in a resting state and unresponsive to IL-12. As shown in Fig. 1A , purified T cells did not proliferate in the absence of exogenous cytokine, and IL-12 induced negligible proliferation of T cells from control mice. In contrast, the proliferative response of SOCS-1 Ϫ/Ϫ T cells to IL-12 was significantly greater, suggesting that these cells were activated and expressed functional IL-12R in vivo (Fig. 1A) .
Due to the poor health and complex phenotype of SOCS-1 (Fig. 1B) . The combination of anti-CD3 and IL-12, however, induced a dose-dependent proliferation by both SOCS-1 Ϫ/Ϫ IFN␥ Ϫ/Ϫ and SOCS-1 ϩ/ϩ IFN␥ Ϫ/Ϫ T cells (Fig. 1B) . SOCS-1 Ϫ/Ϫ IFN␥ Ϫ/Ϫ T cells showed significantly greater proliferation in response to IL-12 than SOCS-1 ϩ/ϩ IFN␥ Ϫ/Ϫ T cells at all IL-12 concentrations tested, and proliferated in response to as little as 0.5 units/ml IL-12 (Fig. 1B) .
To determine which cells were expanding in response to IL-12, the T cell composition of the proliferating cells was analyzed by FACS and was expressed as a ratio of CD8/CD4 cells. The CD8/CD4 ratios in initial populations were ϳ1:1 for T cells of either genotype (Fig. 1C) . These ratios changed slightly after 5 days in culture in the absence of exogenous cytokine (1. (Fig. 1C) . In contrast, IL-12 induced a dose-dependent increase in the ratio of CD8/CD4 cells (to ϳ4.5:1) from SOCS-1 Ϫ/Ϫ IFN␥ Ϫ/Ϫ mice, suggesting that CD8 T cells were more responsive to IL-12 than CD4 T cells (Fig. 1C) . NK and NKT cells were present in negligible numbers in the purified lymph node preparations and did not expand substantially in response to IL-12 (data not shown).
IL-12 Receptor Expression in SOCS-1-deficient T Cells-In-
lymph node T cells may be due to uncontrolled IL-12 signaling in the absence of SOCS-1 and/or as a result of increased IL-12R expression (46) . To distinguish these possibilities, IL-12R expression was analyzed by FACS in both freshly isolated lymph node T cells and cells stimulated with IL-12 in combination with anti-CD3 (Fig. 2) . IL-12R expression was similar in freshly isolated SOCS-1 Ϫ/Ϫ IFN␥ Ϫ/Ϫ and SOCS-1 ϩ/ϩ IFN␥ Ϫ/Ϫ lymph node T cells (Fig. 2) . The combination of IL-12 and anti-CD3 was sufficient to upregulate IL-12R expression on T cells of both genotypes, however, SOCS-1 Ϫ/Ϫ IFN␥ Ϫ/Ϫ T cells up-regulated IL-12R expression faster (by day 2 of culture) and in response to lower doses of IL-12 (0.5 units/ml) than SOCS-1 ϩ/ϩ IFN␥ Ϫ/Ϫ T cells (Fig. 2) . Again, this demonstrates that cells from SOCS-1-deficient mice are hypersensitive to IL-12 and suggests that the enhanced IL-12-induced proliferation of SOCS-1-deficient cells may be due both to increased levels of IL-12R expression and to an intrinsic hyper-responsiveness to IL-12.
IL-12-induced NK Cytotoxicity-A key function of IL-12 is to induce cytotoxic activity in NK cells (32) . We analyzed IL-12-induced NK cytotoxic activity in unsorted splenocytes by measuring lysis of the NK susceptible cell line, YAC-1. Previous analyses have shown that the proportion of splenic NK cells is similar in SOCS-1 Ϫ/Ϫ IFN␥ Ϫ/Ϫ and SOCS-1 ϩ/ϩ IFN␥ Ϫ/Ϫ mice. 2 Negligible cytotoxicity activity of the splenocytes was observed when cultured in media alone (Fig. 3) . IL-12 induced a dosedependent increase in NK activity in both SOCS-1
splenocytes induced maximal specific lysis of target cells when stimulated with 100 units/ml IL-12. In contrast, SOCS-1 ϩ/ϩ IFN␥ Ϫ/Ϫ splenocytes required stimulation with a 10-fold higher dose of IL-12 to achieve this effect.
IL-12 Serum Levels-Since IL-12 promotes IFN␥ production (16 -19) , an increase in IL-12 production could drive the elevated IFN␥ levels seen in SOCS-1 Ϫ/Ϫ mice. We compared the Ϫ/Ϫ mice. STAT4 is believed to the primary mediator of the biological functions of IL-12 (41, 42) . Therefore, SOCS-1 Ϫ/Ϫ STAT4 Ϫ/Ϫ mice were generated to examine the development of the SOCS-1 Ϫ/Ϫ disease in the absence of IL-12 signaling.
As expected from previous studies (9), SOCS-1 Ϫ/Ϫ STAT4 ϩ/ϩ mice became sick during the neonatal period (Fig. 4A ) and developed the characteristic phenotype of SOCS-1 Ϫ/Ϫ mice (data not shown). In contrast, survival of SOCS-1 Ϫ/Ϫ mice was improved by the deletion of STAT4 (Fig. 4A) . All SOCS-1
Ϫ/Ϫ mice survived beyond weaning, but died typically between 1 and 2 months of age (Fig. 4A) . No improvement in survival was seen in SOCS-1 Ϫ/Ϫ STAT4 Ϫ/ϩ mice (Fig. 4A) . As expected, SOCS-1 ϩ/ϩ,ϩ/Ϫ STAT4 Ϫ/Ϫ mice survived until adulthood and were healthy with no detectable abnormalities in lymphoid populations (Fig. 4A and data not shown) . IFN␥ was detectable in the serum of 22% of SOCS-1 Ϫ/Ϫ STAT-4 Ϫ/Ϫ mice (n ϭ 9, data not shown), compared with 100% of SOCS-1
ϩ/ϩ,ϩ/Ϫ mice examined (n ϭ 3, data not shown). Histological analyses of SOCS-1 Ϫ/Ϫ STAT4 Ϫ/Ϫ mice showed the presence of multiple inflammatory lesions in tissues from these mice (Fig. 4B and Table I ). In general, SOCS-1 Ϫ/Ϫ STAT-4 Ϫ/Ϫ mice showed a similar phenotype to that of SOCS-1 Ϫ/Ϫ IFN␥ ϩ/Ϫ mice, which have a similar lifespan (Ref. 14 and Table  I ). For example, skeletal muscle and heart contained inflammatory foci containing lymphocytes, macrophages, and eosinophils. Certain differences, however, were also noted. SOCS-1 Ϫ/Ϫ STAT4 Ϫ/Ϫ mice tended to have less severe skeletal muscle infiltration and more severe infiltration of the heart than SOCS-1 Ϫ/Ϫ IFN␥ ϩ/Ϫ mice, and corneal infiltration and ulcers appeared less common in SOCS-1 Ϫ/Ϫ STAT4 Ϫ/Ϫ mice (Table I) . These minor variations in disease severity may reflect strain differences in the mouse lines. The occurrence of lymphoid foci and infiltrates in the lung were similar in both types of mice ( Fig. 4B and Table I ). The profound liver disease typical of SOCS-1 Ϫ/Ϫ mice was prevented by the removal of STAT4, although some livers appeared not to be entirely healthy, and some reduction in the size of liver parenchymal cells and excessive numbers of lymphocyte-like cells were noted (Table I , data not shown). These changes were also seen in SOCS-1 (14) . In general, the neonatal SOCS-1 Ϫ/Ϫ liver disease was prevented by removing STAT4, but the inflammatory phenotype was still present in various other tissues.
Lymphoid Cellularity of SOCS-1 Ϫ/Ϫ STAT4 Ϫ/Ϫ Mice-The cellularity of lymphoid tissues from SOCS-1 Ϫ/Ϫ STAT4 Ϫ/Ϫ mice was assessed by FACS analysis. Previous work has shown STAT4 Ϫ/Ϫ mice to have normal lymphoid cellularity (42) . In contrast to SOCS-1 Ϫ/Ϫ mice, which are severely B cell lymphopenic (9) , no reduction in B cell number was detected in (12) . Mice lacking both SOCS-1 and IFN␥, however, develop a spectrum of chronic inflammatory diseases as they age and show evidence of immune dysfunction from birth (13) . Uncontrolled responses to IL-12, an inflammatory cytokine, could account for these residual abnormalities in SOCS-1
Further, it has yet to be determined why IFN␥ is present at such high levels in SOCS-1 Ϫ/Ϫ mice. Since IL-12 is a potent inducer of IFN␥, increased sensitivity to this cytokine could also contribute to this abnormality. The data presented here establish that in the absence of SOCS-1, cells are more sensitive to the effects of IL-12. IL-12 induced greater proliferation of both SOCS-1 Ϫ/Ϫ and SOCS-1 Ϫ/Ϫ IFN␥ Ϫ/Ϫ T cells, and increased NK cell cytotoxic activity, compared with their relevant controls.
IL-12 induces the proliferation of activated but not resting T cells due to the differential expression of functional IL-12R (37). Our study showed that IL-12 induces the proliferation of freshly isolated SOCS-1 Ϫ/Ϫ T cells, indicating that these cells are functionally activated. Assessing responses to IL-12 in cells from these mice was complicated therefore by different basal levels of IL-12R expression. To overcome these problems, we used resting T cells from SOCS-1 Ϫ/Ϫ IFN␥ Ϫ/Ϫ mice, which we showed had equivalent IL-12R expression to SOCS-1
T cells showed heightened responses to IL-12 compared with controls.
The observation that SOCS-1 Ϫ/Ϫ IFN␥ Ϫ/Ϫ T cells are hyperresponsive to IL-12 was strengthened by the finding that IL-12R expression by these cells was up-regulated faster and at lower doses of IL-12 in response to stimulation. Therefore, the increased proliferation of SOCS-1 Ϫ/Ϫ IFN␥ Ϫ/Ϫ cells may be attributed both to an initial hyper-responsiveness to IL-12 and resultant greater increases in IL-12R expression.
IL-12 and IFN␥ form a positive feedback loop such that each cytokine drives production of the other (47) . IFN␥ levels are elevated in SOCS-1 Ϫ/Ϫ mice (11), raising the possibility that IL-12 may be driving this overproduction of IFN␥. We were able to detect IL-12 in the serum of only a small proportion of SOCS-1 Ϫ/Ϫ mice. This suggests that IL-12 levels may not be grossly abnormal in SOCS-1 Ϫ/Ϫ mice, although the sensitivity of our assay may be insufficient to detect differences at low IL-12 concentrations. Alternatively, IFN␥-producing cells may be hyper-responsive to IL-12 such that normal levels of IL-12 are sufficient to trigger the overproduction of IFN␥.
The role of IL-12 in the SOCS-1 Ϫ/Ϫ disease was assessed in vivo by generating SOCS-1 Ϫ/Ϫ STAT4 Ϫ/Ϫ mice. These mice showed an attenuation of the SOCS-1 Ϫ/Ϫ disease and improved survival compared with SOCS-1 Ϫ/Ϫ mice. Histological analysis of the SOCS-1 Ϫ/Ϫ STAT4 Ϫ/Ϫ mice showed they lack the profound liver disease that is likely to cause neonatal death in SOCS-1 Ϫ/Ϫ mice, but that chronic inflammation still persists. A variety of SOCS-1 Ϫ/Ϫ mouse models exhibit a similar phenotype. These include SOCS-1 Ϫ/Ϫ IFN␥ ϩ/Ϫ mice (14) , mice that express a mutant SOCS-1 protein that lacks the regulatory SOCS box region (48), SOCS-1 Ϫ/Ϫ mice in which IFN␥ is limited by antibody depletion during the neonatal period (49) , and mice deficient for both SOCS-1 and IFN␣ receptor subunit 1. 4 The feature in common to all may be that IFN␥ is limiting, resulting in a less severe phenotype. Indeed, IFN␥ is only detectable in a small percentage of SOCS-1 Ϫ/Ϫ STAT4 Ϫ/Ϫ mice, and not at the high levels seen in SOCS-1 Ϫ/Ϫ serum. This study suggests, therefore, that hyper-responsiveness to IL-12 may contribute to overproduction of IFN␥ in SOCS-1 Ϫ/Ϫ mice. Until recently, STAT4 was thought to be activated specifically in response to IL-12. However, STAT4 has been shown to mediate signaling in response to a newly identified cytokine IL-23, as well (50) . IL-23 is closely related to IL-12. Both cytokines contain the p40 subunit, signal through STAT4 and have overlapping biological functions (50) . Consequently, the removal of STAT4 abrogates both IL-12 and IL-23 signaling. The attenuated SOCS-1 disease in SOCS-1 Ϫ/Ϫ STAT4 Ϫ/Ϫ mice may be attributed, therefore, to the removal of either IL-12 signaling, IL-23 signaling, or the removal of both cytokines. The generation of SOCS-1 Ϫ/Ϫ IL-12(p35) Ϫ/Ϫ mice, in which only IL-12 signals are affected, would clarify this. 
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